| 注册
首页|期刊导航|中国药业|紫杉醇联合不同铂类术前化学治疗食管鳞癌疗效分析

紫杉醇联合不同铂类术前化学治疗食管鳞癌疗效分析

文兵 吴国俊 明波

中国药业2017,Vol.26Issue(19):62-65,4.
中国药业2017,Vol.26Issue(19):62-65,4.DOI:10.3969/j.issn.1006-4931.2017.19.017

紫杉醇联合不同铂类术前化学治疗食管鳞癌疗效分析

Effect of Paclitaxel Combined with Different Platinum in Preoperative Chemotherapy for Esophageal Squamous Cell Carcinoma

文兵 1吴国俊 1明波1

作者信息

  • 1. 四川省南充市中心医院·川北医学院第二临床学院胸心外科,四川南充 637000
  • 折叠

摘要

Abstract

Objective To investigate the clinical effect of paclitaxel combined with different platinum in preoperative chemotherapy for esophageal squamous cell carcinoma ( ESCC ) . Methods Totally 83 patients with ESCC underwent preoperative chemotherapy in our hos-pital were selected and divided into paclitaxel and cisplatin group ( DP group, 35 cases ) , paclitaxel and nedaplatin group ( NP group, 27 cases ) and paclitaxel and oxaliplatin group ( OP group, 21 cases ) according to different chemotherapy regimen. The general treatment, adverse reactions of chemotherapy drugs and postoperative pathological response were analyzed statistically. Results Compared with OP group, the chemotherapy time of DP group and NP group were shorter ( t=4. 383, 3. 600, P=0. 000, 0. 001 ) , the proportion of thrombo-cytopenia after chemotherapy were less (χ2=7. 367, P=0. 025 ) . The rate of pathological response of tumor cells in DP group and NP group were higher than that in OP group (χ2=4. 978, 3. 884, P=0. 026, 0. 049 ) . Conclusion Preoperative chemotherapy with paclitaxel and cisplatin or nedaplatin is better than oxaliplatin, but it still needs further study.

关键词

紫杉醇/铂类/食管癌/术前/化学治疗

Key words

paclitaxel/platinum/esophageal cancer/preoperative/chemotherapy

分类

医药卫生

引用本文复制引用

文兵,吴国俊,明波..紫杉醇联合不同铂类术前化学治疗食管鳞癌疗效分析[J].中国药业,2017,26(19):62-65,4.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文